Workflow
Six presented abstracts at ASCO-GU 2026 reinforce the clinical impact of Myriad’s Precise MRD, Prolaris, and MyRisk tests
Globenewswire· 2026-02-24 14:00
SALT LAKE CITY, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will present new data at the 2026 ASCO-GU conference supporting its Precise MRDTM (Molecular Residual Disease) Test, Prolaris® Prostate Cancer Prognostic Test and MyRisk® Hereditary Cancer Tests. These data highlight Myriad’s expanding role across the cancer care continuum, including ultra-sensitive molecular residual disease detection, prognostic stratifi ...
From Singapore Success to North American Solutions: Legend Robot Unveils First-of-its-Kind Mobile Spraying Fleet at CONEXPO
Globenewswire· 2026-02-24 14:00
Defining the next era of intelligent construction automation through the lens of master-grade engineering. LAS VEGAS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Amidst a critical skilled labor shortage and rising construction costs in North America, Legend Robot makes its regional debut at CONEXPO-CON/AGG (Booth N12934), introducing the industry’s first "Physical AI" autonomous finishing fleet to modernize interior commercial construction. Solving the Skilled Labor Shortage with Physical AI The North Americ ...
Oncolytics Biotech® to Prioritize Registration-Focused Programs in Anal and Colorectal Cancer
Globenewswire· 2026-02-24 14:00
Company to wind down the GOBLET gastrointestinal study to focus on registration path in the U.S. With sufficient cash on hand to execute near-term milestones, the Company expects to avoid immediate material dilution SAN DIEGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing pelareorep, today announced that it has concluded enrollment in the GOBLET study, having generated the necessary clinical and tr ...
HydroGraph Receives US EPA and UK REACH, and EU REACH Regulatory Clearances for Commercial Scale Graphene Sales Activities
Globenewswire· 2026-02-24 14:00
Key Regulatory Milestones Support Expanded Commercial Activity and Provide Framework for Scale-UpVANCOUVER, British Columbia, Feb. 24, 2026 (GLOBE NEWSWIRE) -- HydroGraph Clean Power Inc. (CSE: HG) (OTCQB: HGRAF) (“HydroGraph” or the “Company”) today announced that the United States Environmental Protection Agency (“EPA”) has issued a TSCA Section 5(e) Order under Premanufacture Notice (PMN) numbers P-24-0086-87 for HydroGraph’s graphene materials described as graphene, turbostratic, 3-9 layers (P-24-0086) ...
Hurricane Grill & Wings Debuts New Location in Lake Jackson, TX
Globenewswire· 2026-02-24 14:00
Florida-Born Wing Brand Brings Signature Wings to Greater Houston Area LOS ANGELES, Feb. 24, 2026 (GLOBE NEWSWIRE) -- FAT (Fresh. Authentic. Tasty.) Brands Inc., parent company of Hurricane Grill & Wings and 17 other restaurant concepts, announces the opening of the first Hurricane Grill & Wings in the greater Houston area, and the second location for the beloved wing brand in Texas. Located in the Plantation Village shopping center, the new Lake Jackson restaurant offers guests a welcoming dining experienc ...
Air Canada Recognized as One of Canada’s Best Diversity Employers for 2026; the Eighth Time in Ten Years
Globenewswire· 2026-02-24 14:00
MONTRÉAL, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Air Canada was named one of Canada's Best Diversity Employers for 2026, the eighth time in a decade the airline has received this recognition. "We’re proud to be recognized for our ongoing commitment to diversity, equity and inclusion. This award spotlights how our employees, resource groups, champions, leaders, and community partners work together to build a more fair, equitable, and inclusive future where everyone feels they belong," said Arielle Meloul-Wechsle ...
Capricor Therapeutics Announces Late-Breaking Presentation at 2026 MDA Clinical and Scientific Conference
Globenewswire· 2026-02-24 14:00
Late-breaking presentation at MDA to feature Phase 3 HOPE-3 results supporting Deramiocel in Duchenne muscular dystrophyHOPE-3 clinical study report (CSR) submitted to the U.S. Food and Drug Administration (FDA) in support of the ongoing BLA review SAN DIEGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that results from its Phase 3 HOPE-3 clini ...
Zoom introduces next-gen Zoom Virtual Agent to automate end-to-end customer resolution
Globenewswire· 2026-02-24 13:56
New virtual agent capabilities reduce customer effort, prevent repeat contacts, and give service leaders confidence to scale automationWith 43% of consumers saying chatbots fail to resolve their issues, Zoom Virtual Agent 3.0 can help organizations close that gap SAN JOSE, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Today Zoom Communications, Inc. (NASDAQ: ZM) unveiled Zoom Virtual Agent 3.0 (ZVA), the next evolution in agentic automation. ZVA introduces a new execution architecture and expanded AI capabiliti ...
Getty Images Set to Capture Stunning Moments from the Milano Cortina 2026 Paralympic Winter Games
Globenewswire· 2026-02-24 13:55
A Media Snippet accompanying this announcement is available by clicking on this link. NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Getty Images (NYSE: GETY), a preeminent global visual content creator and marketplace, today announced its award-winning photographers, editors and operations staff will capture stunning imagery from the Milano Cortina 2026 Paralympic Winter Games. As the Official Photographic Agency of the International Paralympic Committee (IPC), Getty Images will deploy a team of 30 photograp ...
OneMedNet Announces Strategic Neuro Data Partnership with Risorius to Advance EEG-Based Digital Biomarkers
Globenewswire· 2026-02-24 13:53
MINNEAPOLIS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD), a leading provider of regulatory-grade, AI-ready Real-World Data (RWD), today announced a strategic data licensing agreement with Risorius Co., Ltd., a neurotechnology company developing EEG-based digital biomarkers and AI-powered research platforms for central nervous system (CNS) indications across neurology, psychiatry, and sleep. This new relationship supports OneMedNet’s continued focus on expanding its base of subscri ...